BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 35154088)

  • 1. Insights Into the Emergence of Paroxysmal Nocturnal Hemoglobinuria.
    Colden MA; Kumar S; Munkhbileg B; Babushok DV
    Front Immunol; 2021; 12():830172. PubMed ID: 35154088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of T Lymphocytes in the Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria.
    Li C; Dong X; Wang H; Shao Z
    Front Immunol; 2021; 12():777649. PubMed ID: 35003092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria.
    Shingai N; Mizumaki H; Najima Y; Yamada Y; Tran DC; Haraguchi K; Toya T; Okuyama Y; Doki N; Nannya Y; Ogawa S; Nakao S
    Front Immunol; 2023; 14():1329403. PubMed ID: 38288112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
    Maciejewski JP; Sloand EM; Sato T; Anderson S; Young NS
    Blood; 1997 Feb; 89(4):1173-81. PubMed ID: 9028939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations and clonal expansions in paroxysmal nocturnal hemoglobinuria.
    Hosokawa K; Nakao S
    Semin Hematol; 2022 Jul; 59(3):143-149. PubMed ID: 36115691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Boccuni P; Del Vecchio L; Di Noto R; Rotoli B
    Crit Rev Oncol Hematol; 2000 Jan; 33(1):25-43. PubMed ID: 10714960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxysmal nocturnal haemoglobinuria.
    Hill A; DeZern AE; Kinoshita T; Brodsky RA
    Nat Rev Dis Primers; 2017 May; 3():17028. PubMed ID: 28516949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of paroxysmal nocturnal hemoglobinuria].
    Murakami Y
    Rinsho Ketsueki; 2016; 57(10):1900-1907. PubMed ID: 27725586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxysmal nocturnal hemoglobinuria: insights from recent advances in molecular biology.
    Bessler M; Schaefer A; Keller P
    Transfus Med Rev; 2001 Oct; 15(4):255-67. PubMed ID: 11668433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
    Shichishima T
    Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.
    Kawagoe K; Kitamura D; Okabe M; Taniuchi I; Ikawa M; Watanabe T; Kinoshita T; Takeda J
    Blood; 1996 May; 87(9):3600-6. PubMed ID: 8611683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxysmal nocturnal hemoglobinuria.
    Brodsky RA
    Blood; 2014 Oct; 124(18):2804-11. PubMed ID: 25237200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
    Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
    Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment.
    Bravo-Perez C; Guarnera L; Williams ND; Visconte V
    Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in research for pathogenesis of paroxysmal nocturnal hemoglobinuria].
    Murakami Y
    Rinsho Ketsueki; 2021; 62(8):944-953. PubMed ID: 34497235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxysmal nocturnal hemoglobinuria in children.
    van den Heuvel-Eibrink MM
    Paediatr Drugs; 2007; 9(1):11-6. PubMed ID: 17291133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutation and clonal selection in the pathogenesis and in the control of paroxysmal nocturnal hemoglobinuria.
    Bessler M; Hillmen P
    Semin Hematol; 1998 Apr; 35(2):149-67. PubMed ID: 9565157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
    Maciejewski JP; Young NS; Yu M; Anderson SM; Sloand EM
    Thromb Res; 1996 Sep; 83(6):433-47. PubMed ID: 8885138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.